| A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease | 2021-05-10 | 2023-06-24 | |
| A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Chronic Low Back Pain | 2022-12-08 | 2023-06-09 | |
| A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In Participants With Osteoarthritis Pain | 2022-11-22 | 2023-06-05 | |
| A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine | 2021-12-06 | 2023-05-23 | 2024-05-22 |
| A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer | 2020-02-11 | 2023-05-22 | 2024-03-12 |
| A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer | 2020-02-17 | 2023-05-01 | 2024-05-03 |
| A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss | 2021-03-29 | 2023-04-25 | 2024-04-25 |
| A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program | 2021-03-29 | 2023-04-20 | 2024-04-16 |
| A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) | 2020-06-19 | 2023-04-14 | 2024-04-10 |
| A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia) | 2021-05-14 | 2023-04-10 | |
| A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight | 2021-03-29 | 2023-03-16 | 2024-03-08 |
| A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC) | 2020-05-18 | 2023-03-15 | 2023-09-12 |
| A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness | 2020-06-17 | 2023-02-21 | 2022-02-14 |
| A Study of Abemaciclib in Indian Women With Advanced Breast Cancer | 2021-02-22 | 2023-01-09 | 2023-10-31 |
| Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss | 2014-02-28 | 2022-12-27 | 2023-12-14 |
| A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN) | 2021-09-01 | 2022-12-27 | 2023-12-26 |
| A Study of LY3451838 in Participants With Migraine | 2020-11-16 | 2022-11-09 | 2023-11-08 |
| Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain | 2022-01-26 | 2022-10-13 | 2023-10-13 |
| A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin | 2020-10-19 | 2022-10-11 | 2023-10-10 |
| A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes | 2021-04-13 | 2022-10-01 | 2023-08-24 |
| A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus | 2021-09-15 | 2022-09-30 | 2023-09-28 |
| A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4) | 2021-11-16 | 2022-09-09 | 2023-09-07 |
| A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities | 2021-09-29 | 2022-08-25 | 2023-08-23 |
| A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA) | 2020-11-17 | 2022-08-03 | 2023-08-02 |
| A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis | 2021-03-10 | 2022-07-31 | 2023-07-28 |
| A Study of LY3437943 in Participants With Type 2 Diabetes | 2021-05-13 | 2022-07-08 | 2023-06-08 |
| Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back Pain | 2021-10-25 | 2022-06-17 | 2023-06-09 |
| Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain | 2021-05-06 | 2022-06-13 | 2023-10-09 |
| A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes | 2021-08-16 | 2022-06-06 | |
| Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis | 2021-10-12 | 2022-06-06 | 2023-06-01 |
| A Study of LY3437943 in Participants Who Have Obesity or Are Overweight | 2021-05-20 | 2022-05-16 | 2023-08-23 |
| A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes | 2020-12-07 | 2022-04-28 | 2023-04-27 |
| Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer | 2021-01-20 | 2022-04-27 | 2023-04-27 |
| A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis | 2019-05-24 | 2022-04-24 | 2023-04-23 |
| Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis | 2020-02-11 | 2022-04-20 | 2022-12-15 |
| A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) | 2019-09-09 | 2022-04-01 | 2023-03-30 |
| A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight | 2019-12-04 | 2022-04-01 | 2023-03-30 |
| A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer | 2019-09-16 | 2022-03-23 | |
| A Study of LY3041658 in Adults With Hidradenitis Suppurativa | 2020-08-26 | 2022-03-15 | 2023-03-14 |
| Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Chronic Low Back Pain | 2021-05-20 | 2022-02-09 | 2023-10-09 |
| A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) | 2018-09-03 | 2022-02-07 | 2023-02-03 |
| A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range) | 2020-11-04 | 2022-02-04 | 2023-02-03 |
| A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes | 2019-05-29 | 2022-01-10 | 2022-12-21 |
| A Study of LY3462817 in Participants With Rheumatoid Arthritis | 2021-01-04 | 2022-01-10 | 2023-01-05 |
| A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis | 2018-10-19 | 2021-11-03 | 2022-11-02 |
| A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus | 2018-08-02 | 2021-11-01 | 2022-10-11 |
| A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo) | 2019-12-09 | 2021-11-01 | 2022-10-27 |
| Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Osteoarthritis | 2020-11-12 | 2021-10-21 | 2023-10-09 |
| A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis | 2018-06-27 | 2021-10-14 | 2022-10-11 |
| A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus | 2020-07-01 | 2021-10-08 | 2022-10-06 |